Research Site — Centennial, Colorado

Research Site is a clinical research site located in Centennial, Colorado, United States 80112.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 26 clinical trials with 1 currently active.

Therapeutic areas: Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis, Asthma.

Sponsors: Biogen, Pearl Therapeutics, Inc., AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Centennial

Browse all research sites in Colorado · View every site in Centennial

• Rocky Mountain Hospital for Children
• Rocky Mountain Cancer Centers Centennial
• IMMUNOe Research Centers
• GSK Investigational Site
• IMMUNOe International Research Centers
• Octapharma Research Site
• Rocky Mountain Cancer Centers LLP
• Novartis Investigative Site
• Ascendis Pharma Investigational Site
• 1st Allergy and Clinical Research Center
• IMMUNOe International Research Center

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 26 clinical trials on record, with 1 currently active. Their work covers Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis, Asthma.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.